Microcap 101: The Case for the Market's Most Overlooked Segment

Most investors know what a microcap stock is in the abstract. Far fewer understand why serious, experienced investors dedicate careers to this corner of the market. This piece covers both: the fundamentals of what microcap stocks are and where they trade, and the core investment thesis that draws disciplined capital to the space.

This content is for informational and educational purposes only and does not constitute financial advice. Please consult a licensed financial professional for personal investment guidance.

What Is a Microcap Stock?

The SEC defines microcap stocks as shares of public companies with low or micro market capitalizations, typically companies valued at less than $250 million to $300 million. Companies below $50 million are sometimes called nanocap stocks, though the SEC and most practitioners use microcap to cover both.

To put the size in context: a company at the $250 million ceiling of the microcap definition is roughly one-seventh the size of a small-cap stock and less than one-tenth of one percent the size of a name like Apple or Microsoft. These are genuinely small businesses, many of them early-stage, asset-light, or operating in niche markets that larger investors cannot or will not access.

One important clarification: microcap refers to a company's market capitalization, not where its stock trades. A microcap company can be listed on NASDAQ, NYSE American, the New York Stock Exchange, or the OTC market. Market cap and trading venue are separate characteristics.

Where Do Microcap Stocks Trade?

According to a 2022 NASDAQ overview, approximately 7,000 U.S. public microcap companies exist. About 4,300 are exchange-listed and roughly 2,700 trade over the counter. The estimated breakdown by venue:

40 to 50 percent trade on NASDAQ. 10 to 20 percent trade on NYSE American. 35 to 40 percent trade in the OTC market.

No official exchange-by-exchange breakdown of all microcap companies is maintained, so these figures represent industry estimates. The directional picture is clear: exchange-listed microcaps significantly outnumber OTC-traded ones.

Here is a brief overview of each venue and what it means for investors:

NASDAQ

Nasdaq is the largest single home for U.S. microcap companies, particularly growth-oriented businesses. The vast majority of NASDAQ-listed microcaps trade on the NASDAQ Capital Market tier, which was designed specifically for smaller companies that meet a baseline of financial accountability.

Listing requirements include minimum stockholders' equity of $4 to $5 million, a minimum market value of listed securities of $15 million, and at least 300 round-lot shareholders, along with bid price, float, and governance requirements. A Nasdaq-listed microcap has passed an independent review and is subject to delisting if it falls below continued listing thresholds.

NYSE American

NYSE American is a separate national exchange owned by the same parent company as the New York Stock Exchange, Intercontinental Exchange, but it operates under different and more accessible listing standards. NYSE American was specifically designed to accommodate smaller public companies that may not meet the requirements of the main NYSE.

For many experienced microcap investors, NYSE American is an attractive hunting ground precisely because companies listed there typically meet meaningful governance, financial reporting, and listing requirements while still being small enough to offer substantial growth potential. Exchange accountability plus small-company upside is a combination that rewards disciplined research.

The New York Stock Exchange

The NYSE is primarily home to large and mid-cap companies, though some microcap and small-cap issuers maintain listings there.

The OTC Market

The OTC market encompasses the roughly 35 to 40 percent of microcap companies that do not trade on a national exchange. OTC Markets Group organizes these securities into three tiers.

OTCQX Best Market is the top tier, for companies meeting higher financial standards with current disclosures.

OTCQB Venture Market is the middle tier for venture-stage companies requiring current reporting and a minimum bid price.

OTC Pink has no minimum financial standards and ranges from legitimate businesses to shell companies to fraudulent vehicles. Caution is warranted throughout the OTC Pink tier.

For investors building a serious microcap strategy, the opportunity set spans NASDAQ, NYSE American, and the higher-quality OTC tiers: OTCQX and OTCQB. Those three venues contain the vast majority of the U.S. microcap universe worth researching. Experienced investors in this space generally pay far less attention to which exchange a company trades on than to the quality of the business itself.

Why Serious Investors Pay Attention to Microcap

The core thesis behind microcap investing is not that every microcap is a great investment. Most are not. The thesis is that the microcap universe contains a disproportionate share of the market's biggest long-term winners while receiving far less attention than larger companies.

Roughly half of the world's approximately 60,000 publicly listed companies fall into the microcap category under at least one widely used definition. In Canada, approximately 80 percent of listed companies are microcap or venture-stage, reflecting the country's large resource and early-stage issuer market.

One research finding is particularly notable: a study covering May 2012 through May 2022 found that approximately 87 percent of stocks worldwide that appreciated by at least 1,000 percent began as microcap companies. That statistic does not mean most microcaps became 10x winners. It means that most of the market's biggest long-term winners started small.

Several structural characteristics explain why the microcap universe attracts disciplined long-term investors:

The Market Is Less Efficient

Thousands of microcap companies have little or no institutional research coverage. Many have no Wall Street analyst following them at all, creating real opportunities for investors willing to do deep fundamental work.

Institutional Investors Are Often Absent

Large mutual funds, pension funds, and hedge funds frequently cannot build meaningful positions in small, illiquid companies without moving the stock price or violating internal liquidity requirements. That absence leaves more opportunity for individual investors.

Small Companies Have More Room to Grow

A business worth $100 million can become a $1 billion company more readily than a $500 billion company can reach $5 trillion. The mathematical runway for compounding is simply larger.

Information Advantages Are Possible

Investors who read filings closely, develop management relationships, understand an industry, and follow a company over time may identify improving businesses before they attract broad attention.

Discovery Creates Demand

When a company grows from microcap into small-cap or mid-cap territory, it often begins appearing on institutional screens, gains analyst coverage, becomes eligible for more investment mandates, and may be added to major indexes. Those developments can create new and sustained buying interest that did not previously exist.

Why Microcap Gets Little Mainstream Attention

There are several structural reasons why the microcap market receives relatively little mainstream attention. Financial media naturally focuses on large, well-known companies because they attract broader audiences and generate greater reader and viewer interest.

Similarly, many brokerage firms cannot justify assigning research analysts to companies with very small market capitalizations, as the potential investment banking and trading revenue is often limited. Institutional investors face a different constraint.

Funds managing billions of dollars typically cannot build meaningful positions in microcap companies because their limited trading volume and liquidity make it difficult to invest or exit without significantly affecting the stock price. As these funds grow, they naturally migrate toward larger companies, where positions can be scaled to a size that meaningfully impacts overall portfolio performance.

Microcap investing is like searching for gold nuggets in a mountain stream. A lone prospector can stop and collect every promising nugget because even small discoveries are worthwhile. A massive mining operation, however, cannot justify stopping for small finds—it must focus on deposits large enough to move the needle.

The result is a persistent information gap. Because relatively few professional analysts, institutional investors, and media organizations closely follow microcap companies, many receive little independent research or public attention.

For investors willing to conduct thorough due diligence, this lack of coverage can create opportunities to discover undervalued businesses before they become widely recognized. At the same time, the limited availability of reliable information increases the importance of careful research, making the microcap market both higher risk and potentially higher reward than more widely followed segments of the market.

The Risks Are Real

The case for microcap comes with a clear counterweight. The space carries higher business failure rates, lower liquidity and wider bid-ask spreads, greater volatility, higher execution risk, and wide variation in governance quality. These are not abstract risks. They are the primary reason most microcap investors underperform.

Success in microcap investing generally depends less on simply buying microcaps and more on identifying the relatively small number of businesses with exceptional management, durable competitive advantages, expanding markets, and the ability to compound earnings over many years.

The Nursery of Future Leaders

Many long-term investors describe the microcap universe as the market's nursery of future leaders. Today's largest companies, including Nvidia, Amazon, and Apple, all began as much smaller companies before growing into global leaders. The challenge is not finding microcaps. It is distinguishing the rare future compounder from the thousands of companies that never achieve that trajectory. That challenge is exactly what makes the work worth doing for those willing to do it.

The opportunity is real. So is the risk. The difference is the work.

---

The Eliakim Capital Angle

Eliakim Capital's own thesis rests on a similar premise: the biggest opportunities often sit where institutional capital has stopped paying attention. Microcap investing and infrastructure investing are different disciplines, but they share the same core insight. Diligence applied where others have stopped looking is where durable value gets created.

Disclaimer: This article is provided for informational and educational purposes only and should not be construed as investment, legal, tax, or financial advice, or as an offer to buy or sell any security. References to Eliakim Capital, its investment activities, or its clients are provided solely for context and do not constitute a recommendation, endorsement, or solicitation regarding any company, security, or investment strategy. Investing in microcap securities involves substantial risk, including the possible loss of principal. Readers should conduct their own due diligence and consult qualified professional advisors before making any investment decisions.